Tailored α-methylene-γ-butyrolactones and their effects on growth suppression in pancreatic carcinoma cells

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 22, 2010, Pages 6620-6623

  Ramachandran, P Veeraraghavan ^a   Pratihar, Debarshi ^a   Nair, Hari Narayanan G ^a   Walters, Matthew ^a   Smith, Sadie ^a   Yip Schneider, Michele T ^b   Wu, Huangbing ^b   Schmidt, C Max ^b,c,d,e  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Allylboration; Alpha methylene gamma butyrolactones; Anti proliferation; Pancreatic cancer; Parthenolide

Indexed keywords

ALPHA METHYLENE BUTYROLACTONE DERIVATIVE; ANTINEOPLASTIC AGENT; BUTYROLACTONE; PARTHENOLIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PANCREAS ADENOCARCINOMA; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

4-BUTYROLACTONE; CELL DIVISION; CELL LINE, TUMOR; HUMANS; PANCREATIC NEOPLASMS;

AGOUTI PACA;

EID: 77958068349     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.09.022     Document Type: Article

References (31)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun CA Cancer J Clin. 59 2009 225
2. S.M. Kupchan Trans. N. Y. Acad. Sci. 32 1970 85
3. S.M. Kupchan, D.C. Fessler, M.A. Eakin, and T.J. Ciacobbe Science 168 1970 376
4. S.M. Kupchan, M.A. Eakin, and A.M. Thomas J. Med. Chem. 14 1971 1147
5. H. Yoshioka, T.J. Mabre, and B.N. Timmermann Sesquiterpene Lactones 1973 University of Tokoyo Press Tokoyo
6. K. Lesiak, K. Koprowska, I. Zalesna, D. Nejc, M. Duchler, and M. Czyz Melanoma Res. 20 2010 21
7. A.J. Steele, D.T. Jones, K. Ganeshaguru, V.M. Duke, B.C. Yogashangary, J.M. North, M.W. Lowdell, P.D. Kottaridis, A.B. Mehta, A.G. Prentice, A.V. Hoffbrand, and R.G. Wickremasinghe Leukemia 2006 1073
8. M.C. Ralstin, E.A. Gage, M.T. Yip-Schneider, P.J. Klein, E.A. Wiebke, and C.M. Schmidt Mol. Cancer Res. 4 2006 2006
9. L.J. Zhao, Y.H. Xu, and Y. Li J. Dig. Dis. 10 2009 172
10. B.T. Kawasaki, E.M. Hurt, M. Kalathur, M.A. Duhagon, J.A. Milner, Y.S. Kim, and W.L. Farrar Prostate 69 2009 827
11. H. Nakshatri, S.E. Rice, and P. Bhat-Nakshatri Oncogene 23 2004 7330
12. P.V. Ramachandran, M.T. Yip-Schneider, and C.M. Schmidt Future Med. Chem. 1 2009 179
13. J. Skalska, P.S. Brookes, S.M. Nadtochiy, S.P. Hilchey, C.T. Jordan, M.L. Guzman, S.B. Maggirwar, M.M. Briehl, and S.H. Bernstein PLoS One 4 2009 e8115
14. W. Wang, M. Adachi, R. Zhang, J. Zhou, and D.L. Zhu Pancreas 38 2009 e114
15. M.T. Yip-Schneider, H. Nakshatri, C.J. Sweeney, M.S. Marshall, E.A. Wiebke, and C.M. Schmidt Mol. Cancer Ther. 2005 587
16. M.T. Yip-Schneider, H. Wu, V. Njoku, M. Ralstin, B. Holcomb, P.A. Crooks, S. Neelakantan, C.J. Sweeney, and C.M. Schmidt Pancreas 37 2008 e45
17. S. Neelakanatan, S. Nasim, M.I. Guzman, C.T. Jordan, and P.A. Crooks Bioorg. Med. Chem. Lett. 19 2009 4346
18. K.-H. Lee, and H. Furukawa J. Med. Chem. 15 1972 609
19. E. Hejchman, R.D. Haugwitz, and M. Cushman J. Med. Chem. 38 1995 3407
20. M.L. Guzman, R.M. Rossi, S. Neelakantan, X. Li, C.A. Corbett, D.C. Hassane, M.W. Becker, J.M. Bennett, E. Sullivan, J.L. Lachowicz, A. Vaughan, C.J. Sweeney, W. Matthews, M. Carroll, J.L. Liesveld, P.A. Crooks, and C.T. Jordan Blood 110 2007 4427
21. For a recent review, see: R.R.A. Kitson, A. Millemaggi, and R.J.K. Taylor Angew. Chem. Int. Ed. 48 2009 9426
22. For representative reports on the anti-proliferative activity of AMGBLs, see: R. Romagnoli, P.G. Baraldi, M.A. Tabrizi, J. Bermejo, F. Estevez, M. Borgatti, and R. Gambari J. Med. Chem. 48 2005 7906
23. F. Torres, J. Quintana, J. Cabrera, J.F. Loro, F. Leon, J. Bermejo, and F. Estevez Cancer Lett. 269 2008 139
24. T.G. Elford, A. UlaczykLesanko, G. De Pascale, G.D. Wright, and D.G. Hall J. Comb. Chem. 11 2009 155
25. P.V. Ramachandran, D. Pratihar, D. Biswas, A. Srivastava, and M.V. Reddy Org. Lett. 6 2004 481
26. I. Chataigner, J. Lebreton, F. Zammattio, and J. Villiéras Tetrahedron Lett. 38 1997 3719
27. P.V. Ramachandran, M.V.R. Reddy, and M.T. Rudd Chem. Commun. 1999 1979
28. P.V. Ramachandran, D. Pratihar, and D. Biswas Org. Lett. 8 2006 3877
29. Percent cell growth is expressed relative to control treated cells (100%). Bars, mean +/- SEM.
30. P. Rüngeler, V. Castro, G. Mora, N. Gren, W. Vichnewski, H.L. Pahl, I. Merfort, and T.J. Schmidt Bioorg. Med. Chem. 7 1999 2343
31. B. Siedle, A.J. Garcia-Pineres, R. Murillo, J. Schulte-Monting, V. Castro, P. Rungeler, C.A. Klaas, F.B. Da Costa, W. Kisiel, and I. Merfort J. Med. Chem. 47 2004 6042